 | • レポートコード：QYR2104Z0322 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、貧血治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（鉄欠乏性貧血、慢性腎臓病関連貧血、鎌状赤血球貧血、再生不良性貧血）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・貧血治療薬の市場動向 ・企業の競争状況、市場シェア ・貧血治療薬の種類別市場規模（経口、注射） ・貧血治療薬の用途別市場規模（鉄欠乏性貧血、慢性腎臓病関連貧血、鎌状赤血球貧血、再生不良性貧血） ・貧血治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・貧血治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・貧血治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・貧血治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・貧血治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline、Global Blood Therapeutics (GBT)、Bluebird Bio、GlycoMimetics、Mast Therapeutics、Fibrogen、Akebia Therapeutics、Bayer AG、Eli Lilly、Regen Biopharma、Acceleron Pharma、Celgene Corporation、Onconova Therapeutics、Pieris Pharmaceuticals） ・結論 |
Market Analysis and Insights: Global Anemia Drugs Market
The global Anemia Drugs market size is projected to reach US$ 15910 million by 2026, from US$ 11620 million in 2019, at a CAGR of 4.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anemia Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anemia Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anemia Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anemia Drugs market.
Global Anemia Drugs Scope and Market Size
Anemia Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anemia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Oral
Injection
Segment by Application
Iron Deficiency Anemia
Chronic Kidney Disease related Anemia
Sickle Cell Anemia
Aplastic Anemia
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline
Global Blood Therapeutics (GBT)
Bluebird Bio
GlycoMimetics
Mast Therapeutics
Fibrogen
Akebia Therapeutics
Bayer AG
Eli Lilly
GlycoMimetics
Mast Therapeutics
Celgene Corporation
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anemia Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Anemia Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Iron Deficiency Anemia
1.3.3 Chronic Kidney Disease related Anemia
1.3.4 Sickle Cell Anemia
1.3.5 Aplastic Anemia
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anemia Drugs Market Perspective (2016-2027)
2.2 Anemia Drugs Growth Trends by Regions
2.2.1 Anemia Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anemia Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Anemia Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Anemia Drugs Industry Dynamic
2.3.1 Anemia Drugs Market Trends
2.3.2 Anemia Drugs Market Drivers
2.3.3 Anemia Drugs Market Challenges
2.3.4 Anemia Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anemia Drugs Players by Revenue
3.1.1 Global Top Anemia Drugs Players by Revenue (2016-2021)
3.1.2 Global Anemia Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Anemia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anemia Drugs Revenue
3.4 Global Anemia Drugs Market Concentration Ratio
3.4.1 Global Anemia Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anemia Drugs Revenue in 2020
3.5 Anemia Drugs Key Players Head office and Area Served
3.6 Key Players Anemia Drugs Product Solution and Service
3.7 Date of Enter into Anemia Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anemia Drugs Breakdown Data by Type
4.1 Global Anemia Drugs Historic Market Size by Type (2016-2021)
4.2 Global Anemia Drugs Forecasted Market Size by Type (2022-2027)
5 Anemia Drugs Breakdown Data by Application
5.1 Global Anemia Drugs Historic Market Size by Application (2016-2021)
5.2 Global Anemia Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anemia Drugs Market Size (2016-2027)
6.2 North America Anemia Drugs Market Size by Type
6.2.1 North America Anemia Drugs Market Size by Type (2016-2021)
6.2.2 North America Anemia Drugs Market Size by Type (2022-2027)
6.2.3 North America Anemia Drugs Market Size by Type (2016-2027)
6.3 North America Anemia Drugs Market Size by Application
6.3.1 North America Anemia Drugs Market Size by Application (2016-2021)
6.3.2 North America Anemia Drugs Market Size by Application (2022-2027)
6.3.3 North America Anemia Drugs Market Size by Application (2016-2027)
6.4 North America Anemia Drugs Market Size by Country
6.4.1 North America Anemia Drugs Market Size by Country (2016-2021)
6.4.2 North America Anemia Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Anemia Drugs Market Size (2016-2027)
7.2 Europe Anemia Drugs Market Size by Type
7.2.1 Europe Anemia Drugs Market Size by Type (2016-2021)
7.2.2 Europe Anemia Drugs Market Size by Type (2022-2027)
7.2.3 Europe Anemia Drugs Market Size by Type (2016-2027)
7.3 Europe Anemia Drugs Market Size by Application
7.3.1 Europe Anemia Drugs Market Size by Application (2016-2021)
7.3.2 Europe Anemia Drugs Market Size by Application (2022-2027)
7.3.3 Europe Anemia Drugs Market Size by Application (2016-2027)
7.4 Europe Anemia Drugs Market Size by Country
7.4.1 Europe Anemia Drugs Market Size by Country (2016-2021)
7.4.2 Europe Anemia Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anemia Drugs Market Size (2016-2027)
8.2 Asia-Pacific Anemia Drugs Market Size by Type
8.2.1 Asia-Pacific Anemia Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anemia Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anemia Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Anemia Drugs Market Size by Application
8.3.1 Asia-Pacific Anemia Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anemia Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anemia Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Anemia Drugs Market Size by Region
8.4.1 Asia-Pacific Anemia Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anemia Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anemia Drugs Market Size (2016-2027)
9.2 Latin America Anemia Drugs Market Size by Type
9.2.1 Latin America Anemia Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Anemia Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Anemia Drugs Market Size by Type (2016-2027)
9.3 Latin America Anemia Drugs Market Size by Application
9.3.1 Latin America Anemia Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Anemia Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Anemia Drugs Market Size by Application (2016-2027)
9.4 Latin America Anemia Drugs Market Size by Country
9.4.1 Latin America Anemia Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Anemia Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anemia Drugs Market Size (2016-2027)
10.2 Middle East & Africa Anemia Drugs Market Size by Type
10.2.1 Middle East & Africa Anemia Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anemia Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anemia Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Anemia Drugs Market Size by Application
10.3.1 Middle East & Africa Anemia Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anemia Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anemia Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Anemia Drugs Market Size by Country
10.4.1 Middle East & Africa Anemia Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anemia Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Anemia Drugs Introduction
11.1.4 GlaxoSmithKline Revenue in Anemia Drugs Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 Global Blood Therapeutics (GBT)
11.2.1 Global Blood Therapeutics (GBT) Company Details
11.2.2 Global Blood Therapeutics (GBT) Business Overview
11.2.3 Global Blood Therapeutics (GBT) Anemia Drugs Introduction
11.2.4 Global Blood Therapeutics (GBT) Revenue in Anemia Drugs Business (2016-2021)
11.2.5 Global Blood Therapeutics (GBT) Recent Development
11.3 Bluebird Bio
11.3.1 Bluebird Bio Company Details
11.3.2 Bluebird Bio Business Overview
11.3.3 Bluebird Bio Anemia Drugs Introduction
11.3.4 Bluebird Bio Revenue in Anemia Drugs Business (2016-2021)
11.3.5 Bluebird Bio Recent Development
11.4 GlycoMimetics
11.4.1 GlycoMimetics Company Details
11.4.2 GlycoMimetics Business Overview
11.4.3 GlycoMimetics Anemia Drugs Introduction
11.4.4 GlycoMimetics Revenue in Anemia Drugs Business (2016-2021)
11.4.5 GlycoMimetics Recent Development
11.5 Mast Therapeutics
11.5.1 Mast Therapeutics Company Details
11.5.2 Mast Therapeutics Business Overview
11.5.3 Mast Therapeutics Anemia Drugs Introduction
11.5.4 Mast Therapeutics Revenue in Anemia Drugs Business (2016-2021)
11.5.5 Mast Therapeutics Recent Development
11.6 Fibrogen
11.6.1 Fibrogen Company Details
11.6.2 Fibrogen Business Overview
11.6.3 Fibrogen Anemia Drugs Introduction
11.6.4 Fibrogen Revenue in Anemia Drugs Business (2016-2021)
11.6.5 Fibrogen Recent Development
11.7 Akebia Therapeutics
11.7.1 Akebia Therapeutics Company Details
11.7.2 Akebia Therapeutics Business Overview
11.7.3 Akebia Therapeutics Anemia Drugs Introduction
11.7.4 Akebia Therapeutics Revenue in Anemia Drugs Business (2016-2021)
11.7.5 Akebia Therapeutics Recent Development
11.8 Bayer AG
11.8.1 Bayer AG Company Details
11.8.2 Bayer AG Business Overview
11.8.3 Bayer AG Anemia Drugs Introduction
11.8.4 Bayer AG Revenue in Anemia Drugs Business (2016-2021)
11.8.5 Bayer AG Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Anemia Drugs Introduction
11.9.4 Eli Lilly Revenue in Anemia Drugs Business (2016-2021)
11.9.5 Eli Lilly Recent Development
11.10 Regen Biopharma
11.10.1 Regen Biopharma Company Details
11.10.2 Regen Biopharma Business Overview
11.10.3 Regen Biopharma Anemia Drugs Introduction
11.10.4 Regen Biopharma Revenue in Anemia Drugs Business (2016-2021)
11.10.5 Regen Biopharma Recent Development
11.11 Acceleron Pharma
11.11.1 Acceleron Pharma Company Details
11.11.2 Acceleron Pharma Business Overview
11.11.3 Acceleron Pharma Anemia Drugs Introduction
11.11.4 Acceleron Pharma Revenue in Anemia Drugs Business (2016-2021)
11.11.5 Acceleron Pharma Recent Development
11.12 Celgene Corporation
11.12.1 Celgene Corporation Company Details
11.12.2 Celgene Corporation Business Overview
11.12.3 Celgene Corporation Anemia Drugs Introduction
11.12.4 Celgene Corporation Revenue in Anemia Drugs Business (2016-2021)
11.12.5 Celgene Corporation Recent Development
11.13 Onconova Therapeutics
11.13.1 Onconova Therapeutics Company Details
11.13.2 Onconova Therapeutics Business Overview
11.13.3 Onconova Therapeutics Anemia Drugs Introduction
11.13.4 Onconova Therapeutics Revenue in Anemia Drugs Business (2016-2021)
11.13.5 Onconova Therapeutics Recent Development
11.14 Pieris Pharmaceuticals
11.14.1 Pieris Pharmaceuticals Company Details
11.14.2 Pieris Pharmaceuticals Business Overview
11.14.3 Pieris Pharmaceuticals Anemia Drugs Introduction
11.14.4 Pieris Pharmaceuticals Revenue in Anemia Drugs Business (2016-2021)
11.14.5 Pieris Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anemia Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Anemia Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Anemia Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anemia Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Anemia Drugs Market Share by Regions (2016-2021)
Table 8. Global Anemia Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Anemia Drugs Market Share by Regions (2022-2027)
Table 10. Anemia Drugs Market Trends
Table 11. Anemia Drugs Market Drivers
Table 12. Anemia Drugs Market Challenges
Table 13. Anemia Drugs Market Restraints
Table 14. Global Anemia Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Anemia Drugs Market Share by Players (2016-2021)
Table 16. Global Top Anemia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Drugs as of 2020)
Table 17. Ranking of Global Top Anemia Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Anemia Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anemia Drugs Product Solution and Service
Table 21. Date of Enter into Anemia Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anemia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Anemia Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Anemia Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Anemia Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Anemia Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Anemia Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global Anemia Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Anemia Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Anemia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Anemia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Anemia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Anemia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Anemia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Anemia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Anemia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Anemia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Anemia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Anemia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Anemia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Anemia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Anemia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Anemia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Anemia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Anemia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Anemia Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Anemia Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Anemia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Anemia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Anemia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Anemia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Anemia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Anemia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Anemia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Anemia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Anemia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Anemia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Anemia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Anemia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. GlaxoSmithKline Company Details
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Anemia Drugs Product
Table 64. GlaxoSmithKline Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. Global Blood Therapeutics (GBT) Company Details
Table 67. Global Blood Therapeutics (GBT) Business Overview
Table 68. Global Blood Therapeutics (GBT) Anemia Drugs Product
Table 69. Global Blood Therapeutics (GBT) Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 70. Global Blood Therapeutics (GBT) Recent Development
Table 71. Bluebird Bio Company Details
Table 72. Bluebird Bio Business Overview
Table 73. Bluebird Bio Anemia Drugs Product
Table 74. Bluebird Bio Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 75. Bluebird Bio Recent Development
Table 76. GlycoMimetics Company Details
Table 77. GlycoMimetics Business Overview
Table 78. GlycoMimetics Anemia Drugs Product
Table 79. GlycoMimetics Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 80. GlycoMimetics Recent Development
Table 81. Mast Therapeutics Company Details
Table 82. Mast Therapeutics Business Overview
Table 83. Mast Therapeutics Anemia Drugs Product
Table 84. Mast Therapeutics Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 85. Mast Therapeutics Recent Development
Table 86. Fibrogen Company Details
Table 87. Fibrogen Business Overview
Table 88. Fibrogen Anemia Drugs Product
Table 89. Fibrogen Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 90. Fibrogen Recent Development
Table 91. Akebia Therapeutics Company Details
Table 92. Akebia Therapeutics Business Overview
Table 93. Akebia Therapeutics Anemia Drugs Product
Table 94. Akebia Therapeutics Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 95. Akebia Therapeutics Recent Development
Table 96. Bayer AG Company Details
Table 97. Bayer AG Business Overview
Table 98. Bayer AG Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 99. Bayer AG Recent Development
Table 100. Eli Lilly Company Details
Table 101. Eli Lilly Business Overview
Table 102. Eli Lilly Anemia Drugs Product
Table 103. Eli Lilly Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 104. Eli Lilly Recent Development
Table 105. Regen Biopharma Company Details
Table 106. Regen Biopharma Business Overview
Table 107. Regen Biopharma Anemia Drugs Product
Table 108. Regen Biopharma Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 109. Regen Biopharma Recent Development
Table 110. Acceleron Pharma Company Details
Table 111. Acceleron Pharma Business Overview
Table 112. Acceleron Pharma Anemia Drugs Product
Table 113. Acceleron Pharma Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 114. Acceleron Pharma Recent Development
Table 115. Celgene Corporation Company Details
Table 116. Celgene Corporation Business Overview
Table 117. Celgene Corporation Anemia Drugs Product
Table 118. Celgene Corporation Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 119. Celgene Corporation Recent Development
Table 120. Onconova Therapeutics Company Details
Table 121. Onconova Therapeutics Business Overview
Table 122. Onconova Therapeutics Anemia Drugs Product
Table 123. Onconova Therapeutics Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 124. Onconova Therapeutics Recent Development
Table 125. Pieris Pharmaceuticals Company Details
Table 126. Pieris Pharmaceuticals Business Overview
Table 127. Pieris Pharmaceuticals Anemia Drugs Product
Table 128. Pieris Pharmaceuticals Revenue in Anemia Drugs Business (2016-2021) & (US$ Million)
Table 129. Pieris Pharmaceuticals Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anemia Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Anemia Drugs Market Share by Application: 2020 VS 2027
Figure 5. Iron Deficiency Anemia Case Studies
Figure 6. Chronic Kidney Disease related Anemia Case Studies
Figure 7. Sickle Cell Anemia Case Studies
Figure 8. Aplastic Anemia Case Studies
Figure 9. Anemia Drugs Report Years Considered
Figure 10. Global Anemia Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Anemia Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Anemia Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Anemia Drugs Market Share by Regions (2022-2027)
Figure 14. Global Anemia Drugs Market Share by Players in 2020
Figure 15. Global Top Anemia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anemia Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Anemia Drugs Revenue in 2020
Figure 17. Global Anemia Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Anemia Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Anemia Drugs Market Share by Type (2016-2027)
Figure 21. North America Anemia Drugs Market Share by Application (2016-2027)
Figure 22. North America Anemia Drugs Market Share by Country (2016-2027)
Figure 23. United States Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anemia Drugs Market Share by Type (2016-2027)
Figure 27. Europe Anemia Drugs Market Share by Application (2016-2027)
Figure 28. Europe Anemia Drugs Market Share by Country (2016-2027)
Figure 29. Germany Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anemia Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Anemia Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Anemia Drugs Market Share by Region (2016-2027)
Figure 39. China Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anemia Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Anemia Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Anemia Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anemia Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Anemia Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Anemia Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Anemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 59. Global Blood Therapeutics (GBT) Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 60. Bluebird Bio Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 61. GlycoMimetics Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 62. Mast Therapeutics Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 63. Fibrogen Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 64. Akebia Therapeutics Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 65. Bayer AG Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 66. Eli Lilly Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 67. Regen Biopharma Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 68. Acceleron Pharma Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 69. Celgene Corporation Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 70. Onconova Therapeutics Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 71. Pieris Pharmaceuticals Revenue Growth Rate in Anemia Drugs Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の鎌状赤血球貧血治療薬市場規模・現状・予測（2021年-2027年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…- 世界の後天性再生不良性貧血市場規模・現状・予測（2021年-2027年） Acquired aplastic anemia is a rare, serious blood disorder, due to failure of the bone marrow failure to produce blood cells. Bone marrow is the spongy substance found in the center of the bones of the body, in adults mainly the spine, pelvis, and large bones of the legs. Market Analysis and Insight…
- 世界の後天性再生不良性貧血市場規模・現状・予測（2021年-2027年） Acquired aplastic anemia is a rare, serious blood disorder, due to failure of the bone marrow failure to produce blood cells. Bone marrow is the spongy substance found in the center of the bones of the body, in adults mainly the spine, pelvis, and large bones of the legs. Market Analysis and Insight…
- 世界の鉄欠乏性貧血療法市場規模・現状・予測（2021年-2027年） Iron deficiency anemia is anemia that occurs when iron stores cannot meet the needs of normal red blood cell production.This is due to insufficient iron intake, reduced absorption, increased demand, and excess iron deficiency or loss.The morphology is small cell hypochromic anemia.Iron deficiency an…
- 世界の鎌状赤血球貧血治療薬市場規模・現状・予測（2021年-2027年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…